nach oben

Erschienen in:

2012 | OriginalPaper | Buchkapitel

1. Biomaterial Surfaces for the Isolation of Hematopoietic Stem and Progenitor Cells

verfasst von : Srinivas D. Narasipura, Michael R. King

Erschienen in: Engineering Biomaterials for Regenerative Medicine

Verlag: Springer New York

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Enrichment and purification of hematopoietic stem and progenitor cells (HSPCs) is important in basic research as well as in clinical transplantation of HSPCs. Currently, fluorescent-activated cell sorting (FACS) and immunomagnetic separation techniques are widely used for HSPC isolation. Although both methods offer relatively pure subpopulations, FACS can introduce potential sources of contamination and flow cytometers with high-speed sorting ability are prohibitively expensive for smaller laboratories. Immunomagnetic separation requires large amounts of starting material, involves several steps, and furthermore, cell-surface antibodies may prohibit cell proliferation and differentiation. Hence, development of simpler methods for the capture and purification of HSPCs are warranted. By exploiting the differential rolling behavior of CD34+ HSPCs from mature blood cells on selectins, we have developed a flow-based, adhesion molecule-mediated capture method, which may be a viable alternative approach to the isolation of HSPCs.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Nächstes Kapitel Matrix Stiffness: A Regulator of Cellular Behavior and Tissue Formation

Barnett, D., Janossy, G., Lubenko, A., et al.: Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cells. Prepared by the CD34+ haematopoietic stem cell working party. General Haematology Task Force of the British Committee for Standards in Haematology. Clin. Lab. Haematol. 21, 301–308 (1999)CrossRef

Servida, F., Soligo, D., Caneva, L., et al.: Functional and morphological characterization of immunomagnetically selected CD34+ hematopoietic progenitor cells. Stem Cells 14, 430–438 (1996)CrossRef

Cancelas, J.A., Querol, S., Martin-Henao, G., et al.: Isolation of hematopoietic progenitors. An appraoch to two different immunomagnetic methods at the lab scale. Pure Appl. Chem. 68, 1897–1901 (1996)CrossRef

Andrews, R.G., Singer, J.W., Bernstein, I.D.: Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67, 842–845 (1986)

Barnett, D., Granger, V., Storie, I., et al.: Quality assessment of CD34+ stem cell enumeration: experience of the United Kingdom National External Quality Assessment Scheme (UK NEQAS) using a unique stable whole blood preparation. Br. J. Haematol. 102, 553–565 (1998)CrossRef

Baum, C.M., Weissman, I.L., Tsukamoto, A.S., et al.: Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89, 2804–2808 (1992)CrossRef

Civin, C., Banquerigo, M.L., Strauss, L.C., et al.: Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol. 15, 10–17 (1987)

Kondo, M., Wagers, A.J., Manz, M.G., et al.: Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21, 759–806 (2003)CrossRef

Lanza, F., Healy, L., Sutherland, D.R.: Structural and functional features of the CD34 antigen: an update. J. Biol. Regul. Homeost. Agents 15, 1–13 (2001)

10.

Oxley, S.M., Sackstein, R.: Detection of an L-selectin ligand on a hematopoietic progenitor cell line. Blood 84, 3299–3306 (1994)

11.

Rosen, S.D.: Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am. J. Pathol. 155, 1013–1020 (1999)CrossRef

12.

Cornetta, K., Gharpure, V., Mills, B., et al.: Rapid engraftment after allogeneic transplantation using CD34-enriched marrow cells. Bone Marrow Transplant. 21, 65–71 (1998)CrossRef

13.

Lang, P., Schumm, M., Taylor, G., et al.: Clinical scale isolation of highly purified peripheral CD34 + progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant. 24, 583–589 (1999)CrossRef

14.

Pflumio, F., Izac, B., Katz, A., et al.: Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88, 3731–3740 (1996)

15.

Manz, M.G., Miyamoto, T., Akashi, K., et al.: Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99, 11872–11877 (2002)CrossRef

16.

Bhatia, M., Bonnet, D., Murdoch, B., et al.: A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4, 1038–1045 (1998)CrossRef

17.

Benson Jr., D.M., Elder, P.J., Lin, T.S., et al.: High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma. Leuk. Res. 31, 1069–1075 (2007)CrossRef

18.

Copelan, E.A.: Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813–1826 (2006)CrossRef

19.

Farag, S.S., Bolwell, B.J., Elder, P.J., et al.: High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia. Bone Marrow Transplant. 35, 653–661 (2005)CrossRef

20.

Farag, S.S., Elder, P.J., Marcucci, G., et al.: Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged > or = 50 years compared to younger adults with low-risk disease. Bone Marrow Transplant. 31, 87–93 (2003)CrossRef

21.

Marks, D.I., Forman, S.J., Blume, K.G., et al.: A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol. Blood Marrow Transplant. 12, 438–453 (2006)CrossRef

22.

Berenson, R.J., Andrews, R.G., Bensinger, W.I., et al.: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81, 951–955 (1988)CrossRef

23.

Appelbaum, F.R.: The current status of hematopoietic cell transplantation. Annu. Rev. Med. 54, 491–512 (2003)CrossRef

24.

Armitage, J.O.: Bone marrow transplantation. N. Engl. J. Med. 330, 827–838 (1994)CrossRef

25.

Bertolini, F., de Vincentiis, A., Lanata, L., et al.: Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects. Haematologica 82, 220–238 (1997)

26.

Wagner, J.E., Barker, J.N., DeFor, T.E., et al.: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100, 1611–1618 (2002)

27.

Barker, J.N., Davies, S.M., DeFor, T., et al.: Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97, 2957–2961 (2001)CrossRef

28.

Bittencourt, H., Rocha, V., Chevret, S., et al.: Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA identical sibling bone marrow transplantation. Blood 99, 2726–2733 (2002)CrossRef

29.

Guardiola, P., Pasquini, R., Dokal, I., et al.: Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 95, 422–429 (2000)

30.

Elmaagacli, A.H., Peceny, R., Steckel, N., et al.: Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia. Blood 101, 446–453 (2003)CrossRef

31.

Bunin, N., Aplenc, R., Leahey, A., et al.: Outcomes of transplantation with partial T-cell depletion of matched or mismatched unrelated or partially matched related donor bone marrow in children and adolescents with leukemias. Bone Marrow Transplant. 35, 151–158 (2005)CrossRef

32.

Farag, S.S.: Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant. 33, 569–577 (2004)CrossRef

33.

Damiani, D., Sperotto, A., Geromin, A., et al.: Impact of CD34 cell dose on acute graft versus host disease after allogeneic bone marrow stem cell transplantation. Leuk. Lymphoma 43, 2245–2247 (2002)CrossRef

34.

Lemoli, R.M., Cavo, M., Fortuna, A.: Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. J. Hematother. 5, 339–349 (1996)CrossRef

35.

Lowdell, M.W., Theocharous, P.: "Less is More": The Role of Purging in Hematopoietic Stem Cell Transplantation. Oncologist 2, 268–274 (1997)

36.

Bensinger, W., Singer, J., Appelbaum, F., et al.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81, 3158–3163 (1993)

37.

Catley, L., Anderson, K.: Strategies to improve the outcome of stem cell transplantation in multiple myeloma. Hematol. J. 5, 9–23 (2004)CrossRef

38.

Waller, C.F., Bertz, H., Wenger, M.K., et al.: Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen. Bone Marrow Transplant. 18, 279–283 (1996)

39.

Sackstein, R.: The Bone Marrow Is Akin to Skin: HCELL and the Biology of Hematopoietic Stem Cell Homing. J. Inv. Derm. 122, 1061–1069 (2004)

40.

Whetton, A.D., Graham, G.J.: Homing and mobilization in the stem cell niche. Trends Cell Biol. 9, 233–238 (1999)CrossRef

41.

Peled, A., Kollet, O., Ponomaryov, T., et al.: The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95, 3289–3296 (2000)

42.

Chavakis, E., Urbich, C., Dimmeler, S.: Homing and engraftment of progenitor cells: A prerequisite for cell therapy. J. Mol. Cell Cardiol. 45, 514–522 (2008)CrossRef

43.

Frenette, P.S., Subbarao, S., Mazo, I.B., et al.: Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc. Natl Acad. Sci. USA 95, 14423–14428 (1998)CrossRef

44.

Nilsson, S.K., Simmons, P.J.: Transplantable stem cells: home to specific niches. Curr. Opin. Hematol. 11, 102–106 (2004)CrossRef

45.

Orfao, A., Ruiz-Arguelles, A.: General Concepts About Cell Sorting Techniques. Clin. Biochem. 29, 5–9 (1996)CrossRef

46.

Stella, C.C., Cazzola, M., De Fabritiis, P., et al.: CD34-positive cells: biology and clinical relevance. Haematologica 80, 367–387 (1995)

47.

Ibrahim, S.F., van den Engh, G.: High-speed cell sorting: fundamentals and recent advances. Curr. Opin. Biotechnol. 14, 5–12 (2003)CrossRef

48.

Chalmers, J.J., Zborowski, M., Sun, L., et al.: Flow through, immunomagnetic cell separation. Biotechnol. Prog. 14, 141–148 (1998)CrossRef

49.

Johnsen, H.E., Hutchings, M., Taaning, E., et al.: Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separation. Bone Marrow Transplant. 24, 1329–1336 (1999)CrossRef

50.

Hildebrandt, M., Serke, S., Meyer, O., et al.: Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield. Transfusion 40, 507–512 (2000)CrossRef

51.

Martin-Henao, G.A., Picon, M., Amill, B., et al.: Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results. Transfusion 40, 35–43 (2000)CrossRef

52.

de Wynter, E.A., Ryder, D., Lanza, F., et al.: Multicentre European study comparing selection techniques for the isolation of CD34+ cells. Bone Marrow Transplant. 23, 1191–1196 (1999)CrossRef

53.

Firat, H., Giarratana, M.C., Kobari, L., et al.: Comparison of CD34+ bone marrow cells purified by immunomagnetic and immunoadsorption cell separation techniques. Bone Marrow Transplant. 21, 933–938 (1998)CrossRef

54.

Miltenyi, S., Muller, W., Weichel, W., et al.: High gradient magnetic cell separation with MACS. Cytometry 11, 231–238 (1990)CrossRef

55.

Storms, R.W., Goodell, M.A., Fisher, A., et al.: Hoechst dye efflux reveals a novel CD7(+)CD34(−) lymphoid progenitor in human umbilical cord blood. Blood 96, 2125–2133 (2000)

56.

Smith, C.: Hematopoietic stem cells and hematopoiesis. Cancer Control 10, 9–16 (2003)

57.

Goodell, M.A., Rosenzweig, M., Kim, H., et al.: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 3, 1337–1345 (1997)CrossRef

58.

Gallacher, L., Murdoch, B., Wu, D.M., et al.: Isolation and characterization of human CD34(−)Lin(−) and CD34(+)Lin(−) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 95, 2813–2820 (2000)

59.

Kuci, S., Wessels, J.T., Buhring, H.J., et al.: Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. Blood 101, 869–876 (2003)CrossRef

60.

Miraglia, S., Godfrey, W., Yin, A.H., et al.: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013–5021 (1997)

61.

de Wynter, E.A., Buck, D., Hart, C., et al.: CD34 + AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16, 387–396 (1998)CrossRef

62.

Yin, A.H., Miraglia, S., Zanjani, E.D., et al.: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002–5012 (1997)

63.

Handgretinger, R., Gordon, P.R., Leimig, T., et al.: Biology and plasticity of CD133+ hematopoietic stem cells. Ann. NY Acad. Sci. 996, 141–151 (2003)CrossRef

64.

Guo, Y., Lubbert, M., Engelhardt, M.: CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells 21, 15–20 (2003)CrossRef

65.

Andrews, R.G., Singer, J.W., Bernstein, I.D.: Human hematopoietic precursors in long-term culture: single CD34+ cells that lack detectable T cell, B cell, and myeloid cell antigens produce multiple colony forming cells when cultured with marrow stromal cells. J. Exp. Med. 172, 355–358 (1990)CrossRef

66.

Leary, A.G., Ogawa, M., Strauss, L.C., et al.: Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. J. Clin. Invest. 74, 2193–2197 (1984)CrossRef

67.

Kernan, N.A., Bordignon, C., Heller, G., et al.: Graft failure after T-celldepleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74, 2227–2236 (1989)

68.

Keever, C.A., Small, T.N., Flomenberg, N., et al.: Immune reconstitution following bone marrow transplantation: comparison of recipients of Tcell depleted marrow with recipients of conventional marrow grafts. Blood 73, 1340–1350 (1989)

69.

Martinez, C., Urbano-Ispizua, A., Rozman, C., et al.: Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp. Hematol. 27, 561–568 (1999)CrossRef

70.

Daley, J.P., Rozans, M.K., Smith, B.R., et al.: Retarded recovery of functional T cell frequencies in T cell-depleted bone marrow transplant recipients. Blood 70, 960–964 (1987)

71.

Martino, R., Rovira, M., Carreras, E., et al.: Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation. Haematologica 86, 1075–1086 (2001)

72.

Crippa, F., Holmberg, L., Carter, R.A., et al.: Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol. Blood Marrow Transplant. 8, 281–289 (2002)CrossRef

73.

Negrin, R.S., Atkinson, K., Leemhuis, T., et al.: Transplantation of highly purified CD34 + Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol. Blood Marrow Transplant. 6, 262–271 (2000)CrossRef

74.

Hidalgo, A., Weiss, L.A., Frenette, P.S.: Functional selectin ligands mediating human CD34(+) cell interactions with bone marrow endothelium are enhanced postnatally. J. Clin. Invest. 110, 559–569 (2002)

75.

Geng, J.G., Chen, M., Chou, K.C.: P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr. Med. Chem. 11, 2153–2160 (2004)CrossRef

76.

McEver, R.P.: Selectins: lectins that initiate cell adhesion under flow. Curr. Opin. Cell Biol. 14, 581–586 (2002)CrossRef

77.

Konstantopoulos, K., Kukreti, S., McIntire, L.V.: Biomechanics of cell interactions in shear fields. Adv. Drug Deliv. Rev. 33, 141–164 (1998)CrossRef

78.

Kansas, G.S.: Selectins and their ligands: current concepts and controversies. Blood 88, 3259–3287 (1996)

79.

Alon, R., Feizi, T., Yuen, C.T., et al.: Glycolipid ligands for selectins support leukocyte tethering and rolling under physiologic flow conditions. J. Immunol. 154, 5356–5366 (1995)

80.

Geng, J.G., Heavner, G.A., McEver, R.P.: Lectin domain peptides from selectins interact with both cell surface ligands and Ca2+ ions. J. Biol. Chem. 267, 19846–19853 (1992)

81.

Hidalgo, A., Frenette, P.S.: Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood 105, 567–575 (2005)CrossRef

82.

Moore, K.L., Eaton, S.F., Lyons, D.E., et al.: The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, Olinked poly-N-acetyllactosamine. J. Biol. Chem. 269, 23318–23327 (1994)

83.

Greenberg, A.W., Kerr, W.G., Hammer, D.A.: Relationship between selectin mediated rolling of hematopoietic stem and progenitor cells and progression in hematopoietic development. Blood 95, 478–486 (2000)

84.

Greenberg, A.W., Hammer, D.A.: Cell separation mediated by differential rolling adhesion. Biotechnol. Bioeng. 73, 111–124 (2001)CrossRef

85.

Charles, N., Liesveld, J.L., King, M.R.: Investigating the feasibility of stem cell enrichment mediated by immobilized selectins. Biotechnol. Prog. 23, 1463–1472 (2007)CrossRef

86.

Narasipura, S.D., Wojciechowski, J.C., Charles, N., et al.: P-selectin-coated microtube for enrichment of CD341 hematopoietic stem and progenitor cells from human bone marrow. Clin. Chem. 54, 77–85 (2008)CrossRef

87.

Wojciechowski, J.C., Narasipura, S.D., Charles, N., et al.: Capture and enrichment of CD34-positive haematopoietic stem and progenitor cells from blood circulation using P-selectin in an implantable device. Br. J. Haematol. 140, 673–681 (2008)CrossRef

88.

Narasipura, S.D., Wojciechowski, J.C., Duffy, B.M., et al.: Purification of CD45+ hematopoietic cells directly from human bone marrow using a flow-based P-selectin-coated microtube. Am. J. Hematol. 83, 627–629 (2008)CrossRef

89.

Narasipura, S.D., King, M.R.: P-selectin-coated microtube for the purification of CD45+ ematopoietic cells directly from human peripheral blood. Blood Cells Mol. Dis. 42, 136–139 (2009)CrossRef

90.

Rana, K., Liesveld, J.L., King, M.R.: Delivery of apoptotic signal to rolling cancer cells: a novel biomimetic technique using immobilized TRAIL and E-selectin. Biotechnol. Bioeng. 102, 1692–1702 (2009)CrossRef

91.

Han, W., Allio, B.A., Foster, D.G., et al.: Nanoparticle coatings for enhanced capture of flowing cells in microtubes. ACS Nano 4, 174–180 (2010)CrossRef

92.

Hughes, A.D., King, M.R.: Use of naturally occurring halloysite nanotubes for enhanced capture of flowing cells. Langmuir 26, 12155–12164 (2010)CrossRef

93.

Huang, Z., King, M.R.: An immobilized nanoparticle-based platform for efficient gene knockdown of targeted cells in the circulation. Gene Ther. 16, 1271–1282 (2009)CrossRef

94.

Martin, P.J., Hansen, J.A., Buckner, C.D., et al.: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66, 664–672 (1985)

95.

Horowitz, M.M., Gale, R.P., Sondel, P.M., et al.: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555–562 (1990)

96.

Holmberg, L.A., Boeckh, M., Hooper, H., et al.: Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 94, 4029–4035 (1999)

97.

Hong, S., Lee, D., Zhang, H., et al.: Covalent immobilization of p-selectin enhances cell rolling. Langmuir 23, 12261–12268 (2007)CrossRef

Titel: Biomaterial Surfaces for the Isolation of Hematopoietic Stem and Progenitor Cells
verfasst von: Srinivas D. Narasipura
Michael R. King
Verlag: Springer New York
Buch: Engineering Biomaterials for Regenerative Medicine
Print ISBN: 978-1-4614-1079-9

Electronic ISBN: 978-1-4614-1080-5

Copyright-Jahr: 2012
DOI: https://doi.org/10.1007/978-1-4614-1080-5_1

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht